Back to today’s briefing

Story perspectives

Yale Study: Personalized Kidney Cancer Vaccine Shows Promise

6/14/2025

46 3

Summary

Story summary

A groundbreaking Yale study reveals that a personalized kidney cancer vaccine could significantly reduce the risk of recurrence. In a trial with nine patients battling advanced clear cell renal cell carcinoma, all remained cancer-free for over three years. Led by Dr. David A. Braun, this innovative research aims to revolutionize immunotherapy by customizing treatments to each patient's unique genetic profile.

1 of 1

Story summary

A groundbreaking Yale study reveals that a personalized kidney cancer vaccine could significantly reduce the risk of recurrence. In a trial with nine patients battling advanced clear cell renal cell carcinoma, all remained cancer-free for over three years. Led by Dr. David A. Braun, this innovative research aims to revolutionize immunotherapy by customizing treatments to each patient's unique genetic profile.